Man Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $5.02M | Sell |
|
|||||
|
2023
Q4 | $10.3M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $10.5M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $7.55M | Sell |
|
|||||
|
2022
Q3 | $8.77M | Buy |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $510K | Sell |
|
|||||
|
2020
Q4 | $6.25M | Sell |
|
|||||
|
2020
Q3 | $11.1M | Buy |
|
|||||
|
2020
Q2 | $4.81M | Buy |
|
|||||
|
2020
Q1 | $2.54M | Sell |
|
|||||
|
2019
Q4 | $16.8M | Buy |
|
|||||
|
2019
Q3 | $10.4M | Sell |
|
|||||
|
2019
Q2 | $12.9M | Buy |
|
|||||
|
2019
Q1 | $5.2M | Sell |
|
|||||
|
2018
Q4 | $9.55M | Sell |
|
|||||
|
2018
Q3 | $20.8M | Sell |
|
|||||
|
2018
Q2 | $24.8M | Sell |
|
|||||
|
2018
Q1 | $27.1M | Buy |
|